SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acelrx Pharmaceuticals Inc – ‘425’ on 3/25/20 re: Tetraphase Pharmaceuticals Inc

On:  Wednesday, 3/25/20, at 4:01pm ET   ·   Accession #:  1437749-20-6097   ·   File #:  1-35837

Previous ‘425’:  ‘425’ on 3/17/20   ·   Next:  ‘425’ on 4/30/20   ·   Latest:  ‘425’ on 5/29/20

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/20  Acelrx Pharmaceuticals Inc        425                    1:5.9M Tetraphase Pharmaceuticals Inc    RDG Filings/FA

Prospectus or Communication – Business Combination   —   Rule 425   —   SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 425         Prospectus or Communication - Business Combination  HTML     18K

This is an HTML Document rendered as filed.  [ Alternative Formats ]

  Image Exhibit  
 C:  <>  <> 

Filed by AcelRx Pharmaceuticals, Inc.

(Commission File No. 001-35068)

pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

 

Subject Company: Tetraphase Pharmaceutials, Inc.

(Commission File No. 001-35837

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

↑Top
Filing Submission 0001437749-20-006097   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., Apr. 25, 5:14:11.1pm ET